Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Successful CTO: associated to higher survival rate?

Courtesy of Dr. Carlos Fava.

Successful CTO: associated to higher survival rate?The presence of chronic total occlusions (CTO) in coronary angiograms varies between 5% and 30%, depending of the different analyzis. Likewise, they have been associated to higher mortality rate and the need for myocardial revascularization surgery.

 

The frequency of CTO PCI is low across the different series (3.8%), though it might be currently on the rise, as different strategies and devices are made available.

 

The study analyzed 111,273 patients form the Veterans Affairs data base between 2007 and 2013. 29,339 (26.4%) presented at least one CTO. Within this group, patients were usually older, had more risk factors, comorbidities, AMI, prior PCI and myocardial revascularization surgery (CABG).

 

PCI was performed in 2394 patients (8.1%) of those presenting CTO. The procedure was successful in 1908 cases (79.7%). Compared to failed CTO PCI, there were no differences between the groups. The right coronary artery was the one with more CTO; length was 20 mm; most were treated with DES, and 38% also received two stents. Procedural success was higher in the anterior descending artery.

 

Also, success rate increased over the years.

 

At two year follow up, PCI CTO success rate was associated with reduced mortality (hazard ratio: 0.67; 95% CI: 0.47 to 0.95; p<0.02) and less need for CABG (hazard ratio: 0.14; 95% CI 0.08 to 24; p<0.01), with no difference in rehospitalization for MI.

 

Conclusion

Approximately one every 4 patients with obstructive coronary artery disease present one CTO. Among patients undergoing elective PCI for CTO, success rate is 79.7%. Compared to failed CTO PCI, procedural success was associated with a reduction in death rate, as well as reduced need for CABG.

 

Comment

To this day, this is the largest series in the real world, which shows the fact that CTO PCI has increased not only in number, but also in success rate.  Most importantly, this study shows CTO PCI is associated to higher survival rate and less need for CABG, even though a few reports may contradict these results.

 

The higher survival rate at follow up may be explained by the fact that the anterior descending artery had the highest success was achieved, and this significantly reduced residual stenosis.

 

In addition, we should bear in mind we have better devices, drug eluting stents, more experienced operators and improved medical treatments, which are certainly playing a fundamental role in the evolution of these patients.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: Contemporary Incidence, Management and Long-Term Outcomes of Percutaneous of Coronary Intervention for Chronic Artery Total Occlusions.

Reference: Insight from VA CART Program. Thomas T Tsai, et al. J Am Cardiol Intv 2017;10:866-75.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...